Comparison of long-term clinical outcomes between radiofrequency ablation and hepatic resection in patients with small (≤2 cm) hepatocellular carcinoma

被引:0
作者
Hong, Young Mi [1 ,2 ]
机构
[1] Pusan Natl Univ, Sch Med, Dept Internal Med, Yangsan 602739, South Korea
[2] Pusan Natl Univ, Yangsan Hosp, Liver Ctr, Yangsan, South Korea
关键词
ALBI; hepatic resection; hepatocellular carcinoma; overall survival; radiofrequency ablation; SURGICAL RESECTION; LIVER-FUNCTION; PIVKA-II; PROGNOSIS; THERAPY; SERUM; TRIAL;
D O I
10.1080/20450923.2024.2403331
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: The present study aimed to compare the long-term survival outcomes of hepatic resection (HR) and radiofrequency ablation (RFA) in patients with single small (<= 2 cm) hepatocellular carcinoma (HCC). Materials & methods: This retrospective study enrolled patients with a single small HCC measuring 2 cm or smaller underwent HR or RFA as their initial treatment. Results: Overall survival (OS) was significantly higher in the HR group than in the RFA group, while no significant difference was observed in recurrence free survival (RFS) between the two groups. However, after propensity score matching, both OS and RFS in the HR group were significantly higher than in the RFA group. Multivariate analysis showed that patients with hepatitis B virus infection, elevated prothrombin-induced by vitamin K absence or antagonist-II, and albumin-bilirubin (ALBI) grade 2/3 before treatment had poorer OS. Patients with ALBI grade 1 in the HR group demonstrated the highest OS. Conclusion: HR showed significantly better long-term OS and RFS compared with RFA in patients with as a single HCC (<= 2 cm). Moreover, the ALBI grade may help identify patients who would benefit from HR or RFA.
引用
收藏
页数:9
相关论文
共 30 条
  • [1] Global trends and predictions in hepatocellular carcinoma mortality
    Bertuccio, Paola
    Turati, Federica
    Carioli, Greta
    Rodriguez, Teresa
    La Vecchia, Carlo
    Malvezzi, Matteo
    Negri, Eva
    [J]. JOURNAL OF HEPATOLOGY, 2017, 67 (02) : 302 - 309
  • [2] A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma
    Chen, MS
    Li, JQ
    Zheng, Y
    Guo, RP
    Liang, HH
    Zhang, YQ
    Lin, XJ
    Lau, WY
    [J]. ANNALS OF SURGERY, 2006, 243 (03) : 321 - 328
  • [3] Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series
    Choi, Dongil
    Lim, Hyo K.
    Rhim, Hyunchul
    Kim, Young-sun
    Lee, Won Jae
    Paik, Seung Woon
    Koh, Kwang Cheol
    Lee, Joon Hyoek
    Choi, Moon Seok
    Yoo, Byung Chul
    [J]. EUROPEAN RADIOLOGY, 2007, 17 (03) : 684 - 692
  • [4] Surgical resection versus radiofrequency ablation very early-stage HCC (≤2 cm Single HCC): A propensity score analysis
    Chu, Hee Ho
    Kim, Jin Hyoung
    Kim, Pyo Nyun
    Kim, So Yeon
    Lim, Young-Suk
    Park, Seong Ho
    Ko, Heung-Kyu
    Lee, Sung-Gyu
    [J]. LIVER INTERNATIONAL, 2019, 39 (12) : 2397 - 2407
  • [5] EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma (vol 69, pg 182, 2018)
    Galle, Peter R.
    Forner, Alejandro
    Llovet, Josep M.
    Mazzaferro, Vincenzo
    Piscaglia, Fabio
    Raoul, Jean-Luc
    Schirmacher, Peter
    Vilgrain, Valerie
    [J]. JOURNAL OF HEPATOLOGY, 2019, 70 (04) : 817 - 817
  • [6] A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma
    Feng, Kai
    Yan, Jun
    Li, Xiaowu
    Xia, Feng
    Ma, Kuansheng
    Wang, Shuguang
    Bie, Ping
    Dong, Jiahong
    [J]. JOURNAL OF HEPATOLOGY, 2012, 57 (04) : 794 - 802
  • [7] AASLD guidelines for the treatment of hepatocellular carcinoma
    Heimbach, Julie K.
    Kulik, Laura M.
    Finn, Richard S.
    Sirlin, Claude B.
    Abecassis, Michael M.
    Roberts, Lewis R.
    Zhu, Andrew X.
    Murad, M. Hassan
    Marrero, Jorge A.
    [J]. HEPATOLOGY, 2018, 67 (01) : 358 - 380
  • [8] Comparison of liver resection and radiofrequency ablation in long-term survival among patients with early-stage hepatocellular carcinoma: a meta-analysis of randomized trials and high-quality propensity score-matched studies
    Hu, Lingbo
    Lin, Jiangying
    Wang, Aidong
    Shi, Xingpeng
    Qiao, Yingli
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
  • [9] Survival Rates Are Comparable After Radiofrequency Ablation or Surgery in Patients With Small Hepatocellular Carcinomas
    Hung, Hung-Hsu
    Chiou, Yi-You
    Hsia, Cheng-Yuan
    Su, Chien-Wei
    Chou, Yi-Hong
    Chiang, Jen-Huey
    Kao, Wei-Yu
    Huo, Teh-Ia
    Huang, Yi-Hsiang
    Su, Yu-Hui
    Lin, Han-Chieh
    Lee, Shou-Dong
    Wu, Jaw-Ching
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (01) : 79 - 86
  • [10] Clinical and molecular insights into the hepatocellular carcinoma tumour marker des-γ-carboxyprothrombin
    Inagaki, Yoshinori
    Tang, Wei
    Makuuchi, Masatoshi
    Hasegawa, Kiyoshi
    Sugawara, Yasuhiko
    Kokudo, Norihiro
    [J]. LIVER INTERNATIONAL, 2011, 31 (01) : 22 - 35